IndraLab

Statements


3 | 1 3

eidos
"Importantly , our data strongly suggest that concomitant inhibition of JNK1 by JNK-IN-8 in the context of JNK2C116S expression ( and intact JNK2 signaling ) contributes to tumor progression ."

reach
"The result that JNK1 inhibition by JNK-IN-8 is important for synergy with lapatinib is not surprising considering that JNK-IN-8 was shown to have greater activity toward purified, recombinant JNK1 in vitro [XREF_BIBR]."

reach
"JNK-IN-8 potently inhibits JNK1, 2 and 3 enzymatic activity with IC 50 s of 4.7 nM, 18.7 nM and 1.0 nM respectively and inhibits a c-Jun, a direct phosphorylation substrate of JNK, with an EC 50 of 486 nM in Hela cell."

No evidence text available

No evidence text available

No evidence text available

reach
"Importantly, our data strongly suggest that concomitant inhibition of JNK1 by JNK-IN-8 in the context of JNK2 C116S expression (and intact JNK2 signaling) contributes to tumor progression."